The regulation of muscle protein turnover in diabetes

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 10, 2013, Pages 2239-2244

  Workeneh, Biruh ^a   Bajaj, Mandeep ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Insulin resistance; Muscle wasting; Myostatin; Protein energy wasting; Ubiquitin proteasome pathway

Indexed keywords

ACTIVIN A; FATTY ACID; FORKHEAD TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1; INTERLEUKIN 6; MUSCLE PROTEIN; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ARTICLE; BODY COMPOSITION; BODY FAT; CHRONIC KIDNEY DISEASE; CYTOKINE RESPONSE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY TUBULE ACIDOSIS; LIPID DIET; LIPID STORAGE; METABOLIC ACIDOSIS; METABOLIC REGULATION; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTAKE; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; SATELLITE CELL; SKELETAL MUSCLE;

INSULIN RESISTANCE; MUSCLE WASTING; MYOSTATIN; PROTEIN-ENERGY WASTING; UBIQUITIN-PROTEASOME PATHWAY;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84885172924     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.06.028     Document Type: Review

References (61)

1. Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH. Effects of oral sodium bicarbonate in patients with CKD. Clinical Journal of the American Society of Nephrology 2013; 8(5):714-20.
2. Allen DL, Linderman JK, Roy R.R., Bigbee AJ, Grindeland RE, Mukku V, et al Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. American Journal of Physiology 1997; 273: C579-87.
3. Anker SD, Negassa A, Coats A.J., Afzal R., Poole-Wilson PA, Cohn JN, et al Prognostic importance of weight loss in chronic heart failure and the effect of treatment withangiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361:1077-83.
4. Atchley DW, Loeb RF, Richards D.W., Benedict EM, Driscoll ME On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. Journal of Clinical Investigation 1933; 12: 297-326.
5. Bailey JL, Wang X, England B.K., Price SR, Ding X, Mitch WE The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. Journal of Clinical Investigation 1996; 97:1447-53.
6. Bajaj M, Defronzo RA Metabolic and molecular basis of insulin resistance. Journal of Nuclear Cardiology 2003; 10:311-23.
7. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metabolism 2011; 13:11-22.
8. Bassil MS, Gougeon R. Muscle protein anabolism in type 2 diabetes. Current Opinion in Clinical Nutrition & Metabolic Care 2013; 16:83-8.
9. Binns MM, Boehler DA, Lambert DH Identification of the myostatin locus (MSTN) as having a major effect on optimum racing distance in the Thoroughbred horse in the USA. Animal Genetics 2010; 41(Suppl. 2):154-8.
10. Biolo G, Declan Fleming RY, Wolfe RR Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. Journal of Clinical Investigation 1995; 95:811-9.
11. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14:1132-43.
12. Burant CF, Treutelaar MK, Buse MG Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. Journal of Clinical Investigation 1986; 77:260-70.
13. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, et al IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119:285-98.
14. Caro JF, Sinha MK, Raju S.M., Ittoop O., Pories WJ, Flickinger EG, et al Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. Journal of Clinical Investigation 1987; 79:1330-7.
15. Carpenter S, Rigaud M, Barile M., Priest TJ, Perez L, Ferguson JB The Ebers Papyrus. Bard College; 1998.
16. Castaneda C, Bermudez OI, Tucker KL Protein nutritional status and function are associated with type 2 diabetes in Hispanic elders. American Journal of Clinical Nutrition 2000; 72:89-95.
17. Chakravarthy MV, Davis BS, Booth FW IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. Journal of Applied Physiology 2000; 89:1365-79.
18. Cotton JR, Woodard T, Knochel JP Correction of uremic cellular injury with a protein-restricted amino acid-supplemented diet. American Journal of Kidney Diseases 1985; 5:233-6.
19. DCCT. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 2001; 24:1711-21.
20. Di Bari M., van de Poll-Franse LV, Onder G, Kritchevsky SB, Newman A, Harris TB, et al. Antihypertensive medications and differences in muscle mass in older persons: the health, aging and body composition study. Journal of the American Geriatrics Society 2004; 52:961-6.
21. Doehner W, Erdmann E, Cairns R., Clark AL, Dormandy JA, Ferrannini E, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. International Journal of Cardiology 2012; 162:20-6.
22. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression ofp85alpha: the two sides of a coin. Diabetes 2006; 55:2392-7.
23. Felig P, Wahren J, Sherwin R., Palaiologos G. Amino acid and protein metabolism in diabetes mellitus. Archives of Internal Medicine 1977; 137:507-13.
24. Fryburg DA, Jahn LA, Hill S.A., Oliveras DM, Barrett EJ Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. Journal of Clinical Investigation 1995; 96:1722-9.
25. Hebert SL, Nair KS. Protein and energy metabolism in type 1 diabetes. Clinical Nutrition 2010; 29:13-7.
26. Guillet C, Masgrau A, Walrand S., Boirie Y. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obesity Reviews 2012; 13(2):51-7.
27. Heineke J, Auger-Messier M, Xu J., Sargent M, York A, Welle S., et al Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 2010; 121:419-25.
28. Heshka S, Ruggiero A, Bray G.A., Foreyt J., Kahn SE, Lewis CE, et al Altered body composition in type 2 diabetes mellitus. International Journal of Obesity 2008; 32:780-7.
29. Hotamisligil GS, Shargill NS, Spiegelman BM Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
30. Hundal RS, Petersen KF, Mayerson A.B., Randhawa PS, Inzucchi S, Shoelson SE, et al Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal of Clinical Investigation 2002; 109:1321-6.
31. Kelley DE, Mandarino LJ Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000; 49:677-83.
32. Kelly IE, Han TS, Walsh K, Lean ME Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 1999; 22:288-93.
33. Kotler DP. Cachexia. Annals of Internal Medicine 2000; 133:622-34.
34. Major RH, Classics of Medicine Library. Classic Descriptions of Disease: With Biographical Sketches of the Authors. Special Edition New York: Classics of Medicine Library; 1994.
35. McCroskery S, Thomas M, Maxwell L., Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. Journal of Cell Biology 2003; 162:1135-47.
36. McPherron AC, Lee SJ Double muscling in cattle due to mutations in the myostatin gene. Proceedings of the National Academy of Sciences of the United States of America 1997; 94:12457-61.
37. Merforth S, Osmers A, Dahlmann B. Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Molecular Biology Reports 1999; 26:83-7.
38. Mitch WE, Goldberg AL Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. New England Journal of Medicine 1996; 335:1897-905.
39. Muscaritoli M, Anker SD, Argiles J, Aversa Z., Bauer JM, Biolo G, et al Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition ingeriatrics. Clinical Nutrition 2010; 29:154-9.
40. OdegaardJI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339:172-7.
41. Orr R, Fiatarone Singh M. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs 2004; 64:725-50.
42. Park SW, Goodpaster BH, Lee J.S., Kuller LH, Boudreau R, de Rekeneire N, et al Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32:1993-7.
43. Pedersen M, Bruunsgaard H, Weis N., Hendel HW, Andreassen BU, Eldrup E, et al Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mechanisms of Ageing and Development 2003; 124:495-502.
44. Pereira S, Marliss EB, Morais J.A., Chevalier S., Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008; 57:56-63.
45. Pickering WP, Price SR, Bircher G, Marinovic A.C., Mitch WE, Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney International 2002; 61:1286-92.
46. Pupim LB, Heimburger O, Qureshi AR, Ikizler TA, Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney International 2005; 68:2368-74.
47. Rajan V, Mitch WE Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease. Biochimica et Biophysica Acta 2008; 1782:795-9.
48. Reardon KA, Davis J, Kapsa R.M., Choong P., Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle & Nerve 2001; 24:893-9.
49. Rosenfalck AM, Almdal T, Hilsted J., Madsbad S. Body composition in adults with type 1 diabetes at onset and during the first year of insulin therapy. Diabetic Medicine 2002; 19:417-23.
50. Ryerson B, Tierney EF, Thompson T.J., Engelgau MM, Wang J, Gregg EW, et al Excess physical limitations among adults with diabetes in the U.S. population, 1997-1999. Diabetes Care 2003; 26:206-10.
51. Smith RL, Roach PJ, Lawrence JC Jr. Insulin resistance in denervated skeletal muscle. Inability of insulin to stimulate dephosphorylation of glycogen synthase in denervated rat epitrochlearis muscles. Journal of Biological Chemistry 1988; 263:658-65.
52. Song YH, Li Y, Du J., Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. Journal of Clinical Investigation 2005; 115:451-8.
53. Suskin N, McKelvie RS, Burns R.J., Latini R., Pericak D, Probstfield J, et al Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. European Heart Journal 2000; 21:1368-75.
54. Tessari P, Nissen SL, Miles J.M., Haymond MW Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. Journal of Clinical Investigation 1986; 77:575-81.
55. Umpleby AM, Boroujerdi MA, Brown P.M., Carson ER, Sonksen PH The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 1986; 29:131-41.
56. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2:1411-5.
57. Wang X, Hu Z, Hu J., Du J, Mitch WE Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147:4160-8.
58. Whiting DR, Guariguata L, Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 2011; 94:311-21.
59. Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, et al. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. Journal of the American Society of Nephrology 2006; 17:3233-9.
60. Yuan M, Konstantopoulos N, Lee J., Hansen L, Li ZW, Karin M, et al Reversal ofobesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293:1673-7.
61. Zhou X, Wang JL, Lu J, Song Y., Kwak KS, Jiao Q, et al Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010; 142:531-43.